CN103288821A - 巴马亭衍生物及其制备方法与应用 - Google Patents
巴马亭衍生物及其制备方法与应用 Download PDFInfo
- Publication number
- CN103288821A CN103288821A CN2012100512528A CN201210051252A CN103288821A CN 103288821 A CN103288821 A CN 103288821A CN 2012100512528 A CN2012100512528 A CN 2012100512528A CN 201210051252 A CN201210051252 A CN 201210051252A CN 103288821 A CN103288821 A CN 103288821A
- Authority
- CN
- China
- Prior art keywords
- palmatine
- compound
- derivative
- derivative according
- acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
化合物 | 产率% | 熔点/℃ | 氢谱数据(500 MHz,DMSO-d 6) | HR-ESI-MS[M-X]+(calc.)(found) |
1 | 75 | >210℃ | 9.09(1H,s),8.05(1H,s),7.50(1H,s),7.21(1H,d,J=8.0 Hz),6.96(1H,s),6.38(1H,d,J=8.0 Hz), 4.49(2H,t,J=6.0 Hz),3.88 (3H,s),3.81(3H,s),3.72(3H,s),3.05(2H,t,J=6.0 Hz),1.81-1.92(6H,m),1.62(2H,m)。 | C20H20NO4 (338.1392)( 338.1395) |
2 | 81 | >235℃ | 9.58(1H,s),9.01(1H,s),8.20(1H,d,J=9.5 Hz),7.98(1H,d,J=9.5 Hz),7.70(1H,s),7.09(1H,s),5.31(1H,m),4.97(2H,t,J=6.5 Hz),4.05 (3H,s),3.93(3H,s),3.86(3H,s),3.22(2H,t,J=6.5 Hz),1.81-1.92(6H,m),1.62(2H,m)。 | C25H28NO4 +(406.2013)( 406.1998) |
3 | 79 | >232℃ | 9.71(1H,s),9.04(1H,s),8.19(1H,d,J=9.0 Hz),8.01(1H,d,J=9.0 Hz),7.71(1H,s),7.09(1H,s),4.97(2H,t,J=6.0 Hz),4.76(1H,m),4.04(3H,s),3.93(3H,s),3.86(3H,s),3.22(2H,t,J=6.0 Hz),1.82(1H,m),1.72(1H,m),1.32(3H,d,J=6.0 Hz),1.0(3H,d,J=7.5 Hz)。 | C24H28NO4 +(378.17053)( 378.17018) |
4 | 67 | >223℃ | 9.73(1H,s),9.01(1H,s),8.22(1H,d,J=9.5 Hz),8.03(1H,d,J=9.5 Hz),7.70(1H,s),7.58(2H,d,J=7.5 Hz),7.40(2H,t,J=7.5 Hz),7.34(1H,t,J=7.5 Hz),7.09(1H,s),5.35(2H,s),4.93(2H,t,J=6.0 Hz),4.09(3H,s),3.93(3H,s),3.86(3H,s),3.20(2H,t,J=6.0 Hz)。 | C27H26NO4 +(428.18618)( 428.19022) |
5 | 73 | >231℃ | 9.73(1H,s),9.00(1H,s),8.20(1H,d,J=9.0 Hz),8.00(1H,d,J=9.0 Hz),7.70(1H,s),7.09(1H,s), 4.95(1H,t,J=6.0 Hz),4.28(2H,t,J=6.5 Hz),4.05(3H,s),3.91(3H,s),3.86(3H,s),3.20(2H,t,J=6.0 Hz),1.86(2H,m),1.52(2H,m),0.98(3H,d,J=7.5 Hz)。 | C24H28NO4 +(394.20184)( 394.20328) |
6 | 65 | >230℃ | 9.73(1H,s),9.02(1H,s),8.19(1H,d,J=9.0 Hz),8.01(1H,d,J=9.0 Hz),7.71(1H,s),7.09(1H,s), 4.95(2H,t,J=6.0 Hz),4.28(2H,t,J=6.0 Hz),4.04(3H,s),3.93(3H,s),3.86(3H,s),3.22(2H,t,J=7.0Hz),1.87(2H,m),1.46(2H,m),1.24-1.36(8H,m),0.86(3H,t,J=7.0Hz)。 | C28H36NO4 +(450.26443)( 450.26520) |
7 | 56 | Mp >232℃ | 9.77(1H,s),9.02(1H,s),8.22(1H,d,J=9.0Hz),8.03(1H,d,J=9.0Hz),7.70(1H,s),7.62(2H,d,J=8.5Hz), 7.47(2H,d,J=8.5Hz),7.09(1H,s),5.35(2H,s),4.93(2H,t,J=6.0Hz),4.08(3H,s),3.93(3H,s),3.86(3H,s),3.21(2H,t,J=6.0 Hz)。 | C27H25ClNO4 +(462.14721)( 462.14825) |
8 | 84 | >238℃ | 9.80(1H,s),9.02(1H,s),8.20(1H,d,J=9.5Hz),8.02(1H,d,J=9.5Hz),7.71(1H,s),7.09(1H,s),4.96(2H,t,J=5.5 Hz),4.36(2H,q,J=7.5 Hz),4.05(3H,s),3.93(3H,s),3.86(3H,s),3.22(2H,t,J=5.5 Hz),1.45 (3H,t,J=7.5 Hz)。 | C22H24NO4 +(366.42971)( 366.43014) |
9 | 67 | >230℃ | 9.74(1H,s),9.03(1H,s),8.19(1H,d,J=9.0Hz),8.02(1H,d,J=9.0 Hz),7.71(1H,s),7.09(1H,s),4.96(2H,t,J=6.0 Hz),4.28(2H,t,J=6.5 Hz),4.05(3H,s),3.93(3H,s),3.86(3H,s),3.22(2H,t,J=6.5 Hz),1.87(2H,quint,J=7.5 Hz),1.48(2H,m),1.32(4H,m),0.89(3H,t,J=7.5 Hz)。 | C26H32NO4 +(422.23313)( 422.23550) |
10 | 72 | >225℃ | 9.74(1H,s),9.01(1H,s),8.19(1H,d,J=8.5 Hz),8.00(1H,d,J=8.5 Hz),7.70(1H,s),7.09(1H,s),4.95(2H,t,J=6.0 Hz),4.27(2H,t,J=6.5 Hz),4.10(3H,s),3.99(3H,s),3.86(3H,s),3.22(2H,t,J=6.0 Hz),1.86(2H,m),1.25-1.47(14H,m),0.85(3H,t,J=7.5 Hz)。 | C30H40NO4 +(478.29573)( 478.29648) |
11 | 66 | >224℃ | 9.73(1H,s),9.01(1H,s),8.19(1H,d,J=9.0 Hz),8.00(1H,d,J=9.0 Hz),7.70(1H,s),7.09(1H,s),4.95(2H,t,J=6.0 Hz),4.28(2H,t,J=6.5 Hz),4.04(3H,s),3.93(3H,s),3.86(3H,s),3.22(2H,t,J=6.0 Hz),1.86(2H,quint,J=7.5 Hz),1.47(2H,m),1.22-1.35(28H,m),0.85(3H,t,J=6.5 Hz)。 | C38H56NO4 +(590.42093)( 590.41823) |
12 | 72 | >239℃ | 9.84(1H,s),9.05(1H,s),8.21(1H,d,J=9.0 Hz),8.01(1H,d,J=9.0 Hz),7.71(1H,s),7.10(1H,s),4.94(2H,t,J=6.5 Hz),4.61(2H,t,J=6.0 Hz),4.07(3H,s),3.97(3H,s),3.23(2H,t,J=6.0 Hz)。 | C21H19BrNO4 +(428.04975)( 428.05032) |
13 | 62 | >235℃ | 9.84(1H,s),9.03(1H,s),8.29(2H,d,J=8.5 Hz),8.23(1H,d,J=9.5 Hz),8.05(1H,d,J=9.5 Hz),7.89(2H,d,J=8.5 Hz),7.71(1H,s),7.10(1H,s), 5.49(2H,s),4.94(2H,t,J=5.5 Hz),4.06(3H,s),3.93(3H,s),3.87(3H,s),3.22(2H,t,J=5.5 Hz)。 | C27H25N2O6 +(473.17126)( 473.17106) |
14 | 74 | >220℃ | 9.76(1H,s),9.02(1H,s),8.21(1H,d,J=9.0 Hz),8.02(1H,d,J=9.0 Hz),7.70(1H,s),7.09(1H,s), 5.49(2H,s),4.95(2H,t,J=6.5 Hz),4.31(2H,t,J=6.5 Hz),4.05(3H,s),3.93(3H,s),3.86(3H,s),3.68 (2H,t,J=6.5 Hz),3.22(2H,t,J=6.5 Hz) ,2.09 (2H,quint,J=6.5 Hz),1.99 (2H,quint,J=6.5 Hz)。 | C24H27BrNO4 +(472.11235)( 472.11350) |
组别 | 剂量mg/kg | TGmmol/L | TCmmol/L |
模型对照 | —— | 6.24±1.05## | 43.39±10.26## |
空白对照 | —— | 0.94±0.12**## | 1.63 ±0.17**## |
辛伐他汀 | 0.83 | 3.17±0.93** | 28.00±4.67** |
化合物2低剂量 | 5 | 4.46±1.90* | 33.18±7.26* |
化合物2中剂量 | 10 | 3.82±1.46** | 24.88±5.00** |
化合物2高剂量 | 20 | 3.65±1.12** | 25.04±7.23** |
化合物4低剂量 | 5 | 4.55±1.95* | 32.24±9.73* |
化合物4中剂量 | 10 | 4.29±1.54* | 28.54±5.89** |
化合物4高剂量 | 20 | 4.21±2.21* | 24.67±3.55** |
化合物5低剂量 | 5 | 4.05±0.94** | 26.39±6.18** |
化合物5中剂量 | 10 | 3.18±1.80** | 23.29±4.15** |
化合物5高剂量 | 20 | 2.43±1.32** | 22.95±4.88** |
化合物9低剂量 | 5 | 4.34±1.90* | 31.69±2.77* |
化合物9中剂量 | 10 | 4.20±2.06* | 28.60±4.22** |
化合物9高剂量 | 20 | 4.08±1.63** | 25.75±3.36** |
化合物12低剂量 | 5 | 4.39±1.99* | 30.15±6.79** |
化合物12中剂量 | 10 | 3.87±1.62** | 24.07±2.31** |
化合物12高剂量 | 20 | 3.49±1.93** | 23.46±4.11** |
组别 | 剂量mg/kg | 血糖mol/L |
模型对照 | —— | 25.9±7.8## |
空白对照 | —— | 6.1±0.3**## |
二甲双胍 | 225 | 12.3±5.1** |
化合物2低剂量 | 5 | 17.3±5.8* |
化合物2中剂量 | 10 | 17.0±5.5** |
化合物2高剂量 | 20 | 15.0±3.1** |
化合物4低剂量 | 5 | 17.6±6.3* |
化合物4中剂量 | 10 | 14.7±4.2** |
化合物4高剂量 | 20 | 13.7±1.1** |
化合物5低剂量 | 5 | 14.2±5.5** |
化合物5中剂量 | 10 | 13.1±1.5** |
化合物5高剂量 | 20 | 10.0±0.6** |
化合物9低剂量 | 5 | 16.6±5.3* |
化合物9中剂量 | 10 | 15.5±2.2** |
化合物9高剂量 | 20 | 14.3±1.4** |
化合物12低剂量 | 5 | 16.5±5.3** |
化合物12中剂量 | 10 | 12.6±2.6** |
化合物12高剂量 | 20 | 11.8±3.7** |
Claims (11)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2012100512528A CN103288821A (zh) | 2012-03-01 | 2012-03-01 | 巴马亭衍生物及其制备方法与应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2012100512528A CN103288821A (zh) | 2012-03-01 | 2012-03-01 | 巴马亭衍生物及其制备方法与应用 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN103288821A true CN103288821A (zh) | 2013-09-11 |
Family
ID=49090405
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2012100512528A Pending CN103288821A (zh) | 2012-03-01 | 2012-03-01 | 巴马亭衍生物及其制备方法与应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103288821A (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106083842A (zh) * | 2016-06-29 | 2016-11-09 | 合肥华方医药科技有限公司 | 9‑位取代的双功能团小檗碱衍生物的制备方法及用途 |
CN108101902A (zh) * | 2017-12-27 | 2018-06-01 | 四川大学 | 高b环小檗碱和巴马亭衍生物的合成及作为降血糖的用途 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1582930A (zh) * | 2004-06-10 | 2005-02-23 | 西安交通大学 | 中药成分盐酸巴马汀在治疗ⅱ型糖尿病疾病中的用途 |
CN100999522A (zh) * | 2006-01-09 | 2007-07-18 | 金伟平 | 巴马汀的制备方法 |
US20100120810A1 (en) * | 2007-07-12 | 2010-05-13 | Bertrand Leblond | Compounds and methods for modulating rho gtpases |
-
2012
- 2012-03-01 CN CN2012100512528A patent/CN103288821A/zh active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1582930A (zh) * | 2004-06-10 | 2005-02-23 | 西安交通大学 | 中药成分盐酸巴马汀在治疗ⅱ型糖尿病疾病中的用途 |
CN100999522A (zh) * | 2006-01-09 | 2007-07-18 | 金伟平 | 巴马汀的制备方法 |
US20100120810A1 (en) * | 2007-07-12 | 2010-05-13 | Bertrand Leblond | Compounds and methods for modulating rho gtpases |
Non-Patent Citations (1)
Title |
---|
黄绍智等: "C-9不同位阻取代小檗碱衍生物的合成及对DNA键合作用的影响", 《中山大学学报(自然科学版)》 * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106083842A (zh) * | 2016-06-29 | 2016-11-09 | 合肥华方医药科技有限公司 | 9‑位取代的双功能团小檗碱衍生物的制备方法及用途 |
CN106083842B (zh) * | 2016-06-29 | 2019-02-15 | 合肥华方医药科技有限公司 | 9-位取代的双功能团小檗碱衍生物的制备方法及用途 |
CN108101902A (zh) * | 2017-12-27 | 2018-06-01 | 四川大学 | 高b环小檗碱和巴马亭衍生物的合成及作为降血糖的用途 |
CN108101902B (zh) * | 2017-12-27 | 2020-05-15 | 四川大学 | 高b环小檗碱和巴马亭衍生物的合成及作为降血糖的用途 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20070027181A1 (en) | Benzylisoquinoline derivative- or bisbenzylisoquinoline derivative-containing psychotropic agent, analgesic and/or antiphlogistic, and health food | |
US11925665B2 (en) | Extract effective in treating drug addiction | |
CN103989677A (zh) | 去亚甲基小檗碱在制备降血糖药物中的应用 | |
AU2012276114A1 (en) | Substituted cinnamamide derivative, preparation method and use thereof | |
CN101712709A (zh) | 三乙酰基-3-羟基苯基腺苷及其调血脂的用途 | |
CN103919775A (zh) | 9-去甲基小檗碱在制备降血糖药物中的应用 | |
CN103041197A (zh) | 治疗高血压的中药组合物 | |
CN105769846A (zh) | 一种gpr35激动剂及其应用 | |
CN101926865B (zh) | 酸枣仁解郁安神组合物及其制备方法 | |
EP3786158A1 (en) | Cyclohexenyl compounds, compositions comprising them and uses thereof | |
CN103288821A (zh) | 巴马亭衍生物及其制备方法与应用 | |
JP2016508489A (ja) | プロトパナキサジオール誘導体、その製造方法及びその応用 | |
CN102153614B (zh) | 止泻木总生物碱提取物的有效单体制备方法及其用途 | |
CN101632646B (zh) | 一种盐酸奥洛他定片及其制备方法和检测方法 | |
CN100404534C (zh) | 小檗碱衍生物在制备治疗2型糖尿病、调节血糖和血脂的药物中的应用 | |
CN102659905B (zh) | 一种常春藤皂苷元衍生物及其制备方法和应用 | |
CN106349099B (zh) | 咖啡酸-赖氨酸及其衍生物、制备方法和用途 | |
CN101411711B (zh) | 泽泻醇a和泽泻醇a 24-乙酸酯组成的组合物及应用 | |
CN105777520A (zh) | 一种新型查尔酮化合物Chalcone-1203及其组合物、制备方法和应用 | |
CN106083842B (zh) | 9-位取代的双功能团小檗碱衍生物的制备方法及用途 | |
CN101429191A (zh) | 取代的四氢异喹啉衍生物的用途 | |
CN103919774A (zh) | 去亚甲基小檗碱在制备降血脂药物中的应用 | |
CN106974916A (zh) | 奥贝胆酸和二甲双胍的复方组合物及其应用 | |
CN106176740B (zh) | 紫堇达明抗成瘾的医药用途 | |
CN112168831B (zh) | 一个雷公藤内酯醇衍生物在防治炎症性肠病中的用途 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C53 | Correction of patent of invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Lv Ziming Inventor after: Wang Hongtao Inventor after: Liang Junqing Inventor after: Zhao Shaohua Inventor after: Li Xiangjun Inventor after: Tian Shuyan Inventor after: Wu Yiling Inventor before: Lv Ziming Inventor before: Wang Hongtao Inventor before: Liang Junqing Inventor before: Zhao Shaohua Inventor before: Li Xiangjun Inventor before: Tian Shuyan Inventor before: Wu Yiling |
|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20130911 |